Bristol Myers Squibb EPS - Earnings per Share 2010-2022 | BMY

Bristol Myers Squibb annual and quarterly earnings per share history from 2010 to 2022. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • Bristol Myers Squibb EPS for the quarter ending March 31, 2022 was $0.59, a 33.71% decline year-over-year.
  • Bristol Myers Squibb EPS for the twelve months ending March 31, 2022 was $2.82, a 202.17% decline year-over-year.
  • Bristol Myers Squibb 2021 annual EPS was $3.12, a 178.2% decline from 2020.
  • Bristol Myers Squibb 2020 annual EPS was $-3.99, a 298.51% decline from 2019.
  • Bristol Myers Squibb 2019 annual EPS was $2.01, a 33.22% decline from 2018.
Bristol Myers Squibb Annual EPS
2021 $3.12
2020 $-3.99
2019 $2.01
2018 $3.01
2017 $0.61
2016 $2.65
2015 $0.93
2014 $1.20
2013 $1.54
2012 $1.16
2011 $2.16
2010 $1.79
2009 $5.34
Bristol Myers Squibb Quarterly EPS
2022-03-31 $0.59
2021-12-31 $1.07
2021-09-30 $0.69
2021-06-30 $0.47
2021-03-31 $0.89
2020-12-31 $-4.43
2020-09-30 $0.82
2020-06-30 $-0.04
2020-03-31 $-0.34
2019-12-31 $-0.73
2019-09-30 $0.83
2019-06-30 $0.87
2019-03-31 $1.04
2018-12-31 $0.71
2018-09-30 $1.16
2018-06-30 $0.23
2018-03-31 $0.91
2017-12-31 $-1.40
2017-09-30 $0.51
2017-06-30 $0.56
2017-03-31 $0.94
2016-12-31 $0.53
2016-09-30 $0.72
2016-06-30 $0.69
2016-03-31 $0.71
2015-12-31 $-0.12
2015-09-30 $0.42
2015-06-30 $-0.08
2015-03-31 $0.71
2014-12-31 $0.01
2014-09-30 $0.43
2014-06-30 $0.20
2014-03-31 $0.56
2013-12-31 $0.43
2013-09-30 $0.42
2013-06-30 $0.32
2013-03-31 $0.37
2012-12-31 $0.57
2012-09-30 $-0.43
2012-06-30 $0.38
2012-03-31 $0.64
2011-12-31 $0.51
2011-09-30 $0.56
2011-06-30 $0.52
2011-03-31 $0.57
2010-12-31 $0.28
2010-09-30 $0.55
2010-06-30 $0.53
2010-03-31 $0.43
2009-12-31 $4.05
2009-09-30 $0.48
2009-06-30 $0.49
2009-03-31 $0.32
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $163.299B $46.385B
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in New York.
Stock Name Country Market Cap PE Ratio
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.420B 16.45
Biohaven Pharmaceutical Holding (BHVN) United States $10.085B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.716B 0.00
Emergent Biosolutions (EBS) United States $1.842B 7.89
Arcus Biosciences (RCUS) United States $1.368B 34.69
Myovant Sciences (MYOV) United Kingdom $0.984B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.517B 0.00
Gelesis Holdings (GLS) United States $0.358B 0.00
Zymeworks (ZYME) Canada $0.354B 0.00
Ambrx Biopharma (AMAM) United States $0.157B 0.00
Enzo Biochem (ENZ) United States $0.117B 24.10
SQZ Biotechnologies (SQZ) United States $0.095B 0.00